235 related articles for article (PubMed ID: 28483551)
1. Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses.
Courtin N; Fotso AF; Fautrad P; Mas F; Alessi MC; Riteau B
Antiviral Res; 2017 Jul; 143():252-261. PubMed ID: 28483551
[TBL] [Abstract][Full Text] [Related]
2. The Annexin A1 Receptor FPR2 Regulates the Endosomal Export of Influenza Virus.
Rahman F; Chebbo M; Courtin N; Fotso Fotso A; Alessi MC; Riteau B
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29738458
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
4. Germacrone inhibits early stages of influenza virus infection.
Liao Q; Qian Z; Liu R; An L; Chen X
Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
[TBL] [Abstract][Full Text] [Related]
6. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
[TBL] [Abstract][Full Text] [Related]
7. [Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models].
Leneva IA; Fediakina IT; Eropkin MIu; Gudova NV; Romanovskaia AA; Danilenko DM; Vinogradova SM; Lepeshkin AIu; Shestopalov AM
Vopr Virusol; 2010; 55(3):19-27. PubMed ID: 20608077
[TBL] [Abstract][Full Text] [Related]
8. Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.
Gao L; Han J; Si J; Wang J; Wang H; Sun Y; Bi Y; Liu J; Cao L
Antiviral Res; 2017 Jul; 143():106-112. PubMed ID: 28232246
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.
Matusevich OV; Egorov VV; Gluzdikov IA; Titov MI; Zarubaev VV; Shtro AA; Slita AV; Dukov MI; Shurygina AP; Smirnova TD; Kudryavtsev IV; Vasin AV; Kiselev OI
Antiviral Res; 2015 Jan; 113():4-10. PubMed ID: 25446335
[TBL] [Abstract][Full Text] [Related]
10. Inhibition effects of novel polyketide compound PPQ-B against influenza A virus replication by interfering with the cellular EGFR pathway.
Wang M; Wang S; Wang W; Wang Y; Wang H; Zhu W
Antiviral Res; 2017 Jul; 143():74-84. PubMed ID: 28414053
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of influenza virus replication by adlay tea.
Nagai E; Iwai M; Koketsu R; Sogabe R; Morimoto R; Suzuki Y; Ohta Y; Okuno Y; Ohshima A; Enomoto T; Isegawa Y
J Sci Food Agric; 2018 Mar; 98(5):1899-1905. PubMed ID: 28902408
[TBL] [Abstract][Full Text] [Related]
12. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X
Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202
[TBL] [Abstract][Full Text] [Related]
13. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral.
Hu Y; Zhang J; Musharrafieh R; Hau R; Ma C; Wang J
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885544
[TBL] [Abstract][Full Text] [Related]
14. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2014 Feb; 20(2):77-80. PubMed ID: 24560563
[TBL] [Abstract][Full Text] [Related]
15. In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate.
Ilyushina NA; Donnelly RP
Antiviral Res; 2014 Nov; 111():112-20. PubMed ID: 25245230
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of an aqueous extract derived from Aloe arborescens Mill. against a broad panel of viruses causing infections of the upper respiratory tract.
Glatthaar-Saalmüller B; Fal AM; Schönknecht K; Conrad F; Sievers H; Saalmüller A
Phytomedicine; 2015 Sep; 22(10):911-20. PubMed ID: 26321740
[TBL] [Abstract][Full Text] [Related]
17. Influenza virus resistance to antiviral agents: a plea for rational use.
Poland GA; Jacobson RM; Ovsyannikova IG
Clin Infect Dis; 2009 May; 48(9):1254-6. PubMed ID: 19323631
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system.
Patel U; Gingerich A; Widman L; Sarr D; Tripp RA; Rada B
PLoS One; 2018; 13(7):e0199167. PubMed ID: 30044776
[TBL] [Abstract][Full Text] [Related]
19. Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season.
Zaraket H; Saito R; Wakim R; Tabet C; Medlej F; Reda M; Baranovich T; Suzuki Y; Dapat C; Caperig-Dapat I; Dbaibo GS; Suzuki H
J Med Virol; 2010 Jul; 82(7):1224-8. PubMed ID: 20513088
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolic acid, an immunomodulator, has potent and broad-spectrum in vitro antiviral activity against pandemic, seasonal and avian influenza viruses affecting humans.
To KKW; Mok KY; Chan ASF; Cheung NN; Wang P; Lui YM; Chan JFW; Chen H; Chan KH; Kao RYT; Yuen KY
J Gen Virol; 2016 Aug; 97(8):1807-1817. PubMed ID: 27259985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]